secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001437749-24-000902
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen begins using updated corporate presentation on January 8, 2024
-----------------------------------------------------------------------

- New corporate presentation adopted by Vistagen Therapeutics on Jan 8, 2024.
- Presentation attached as Exhibit 99.1; no financial or pipeline details provided in the filing.
- Item 7.01 disclosure; information is furnished, not filed, under SEC rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924000902/0001437749-24-000902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924000902/vtgn20240108_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-000902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer